Japón

Vietnam’s pharmaceutical industry is experiencing a period of significant expansion, emerging as the second-fastest growing market in Asia, trailing only India. This growth is fueled by a combination of factors, including increasing healthcare spending, a growing population, and rising rates of chronic diseases. Projections indicate that per capita healthcare expenditure in Vietnam will reach $78.3 USD by 2025, demonstrating a strong commitment to improving public health infrastructure and access to medical care.

The Vietnamese pharmaceutical market is estimated to be worth $8 billion in total spending in 2025, with approximately $3.5 billion attributed to imports. These imports span a range of pharmaceutical products, from branded medications originating in Europe and high-value patented drugs, to biotechnology products and specialized medicines from the United States, and a diverse array of more affordable options from partners like South Korea and India. The remaining portion of the market is met by domestically produced pharmaceuticals, signaling a growing capacity for local manufacturing.

Growth Outpaces Regional Neighbors

The annual compound growth rate of Vietnam’s pharmaceutical sector surpasses that of several other key Asian economies, including Malaysia, Indonesia, South Korea, Taiwan, Thailand, Singapore, and the Philippines. This rapid expansion positions Vietnam as an increasingly attractive destination for foreign investment and a key player in the regional pharmaceutical landscape. The country’s strategic location and favorable trade policies further contribute to its growing prominence.

Export Expansion and Domestic Production

In 2025, 67 Vietnamese companies are projected to export pharmaceutical products and raw materials to Asian countries, Europe, and Japan, totaling $312 million in export value. This positions Vietnam as the fourth-largest exporter of pharmaceuticals in Southeast Asia. Foreign direct investment (FDI) plays a significant role in these exports, accounting for $230 million, while domestically owned companies contribute $82 million. This demonstrates a blend of international collaboration and growing domestic capabilities.

Quality Control and Regulatory Oversight

Maintaining the quality and safety of pharmaceutical products is a priority for Vietnamese authorities. The Department of Drug Administration reported that of 40,000 drug samples analyzed in 2025, 0.6% were found to be substandard, and 0.024% were identified as counterfeit. A total of 82 batches of medications were recalled due to quality violations, with 11 recalls occurring at the national level and 71 at the local level. 46 foreign-owned pharmaceutical manufacturers have faced sanctions, requiring them to inspect all imported batches to ensure compliance with Vietnamese regulations.

Cosmetics Market Also Sees Strong Growth

Beyond pharmaceuticals, Vietnam’s cosmetics market is also experiencing substantial growth. In the first ten months of 2025, the country imported $1.27 billion worth of cosmetic products. The largest sources of these imports were the ASEAN countries ($560 million), South Korea ($200 million), China ($170 million), Europe ($110 million), and Japan ($50 million). This highlights the increasing demand for beauty and personal care products within Vietnam.

The Vietnamese pharmaceutical industry’s trajectory suggests a continued period of growth and innovation. Ongoing investments in research and development, coupled with a supportive regulatory environment, are expected to further enhance the country’s capabilities in pharmaceutical manufacturing and export. The increasing focus on quality control and patient safety will be crucial in maintaining consumer confidence and attracting further investment.

Looking ahead, the Vietnamese government is expected to continue implementing policies aimed at strengthening the pharmaceutical sector, promoting local production, and attracting foreign investment. The industry’s ability to adapt to evolving global trends and address emerging healthcare challenges will be key to sustaining its impressive growth momentum.

What are your thoughts on the future of the pharmaceutical industry in Vietnam? Share your comments below.

Disclaimer: This article provides informational content only and should not be considered medical or financial advice. Consult with a qualified healthcare professional or financial advisor for personalized guidance.